<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82050</article-id><article-id pub-id-type="doi">10.7554/eLife.82050</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses can originate from cross-reactive CMV-specific T cells</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-286992"><name><surname>Pothast</surname><given-names>Cilia R</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9761-3123</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287861"><name><surname>Dijkland</surname><given-names>Romy C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180922"><name><surname>Thaler</surname><given-names>Melissa</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5590-4918</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287862"><name><surname>Hagedoorn</surname><given-names>Renate S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287863"><name><surname>Kester</surname><given-names>Michel GD</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287864"><name><surname>Wouters</surname><given-names>Anne K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-157000"><name><surname>Hiemstra</surname><given-names>Pieter S</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287878"><name><surname>van Hemert</surname><given-names>Martijn J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-238436"><name><surname>Gras</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287879"><name><surname>Falkenburg</surname><given-names>JH Frederik</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287880"><name><surname>Heemskerk</surname><given-names>Mirjam HM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Hematology</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Department of Medical Microbiology</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">Department of Pulmonology</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff4"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Monash University</institution>, <addr-line><named-content content-type="city">Clayton</named-content></addr-line>, <country>Australia</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-18113"><name><surname>Belz</surname><given-names>Gabrielle T</given-names></name><role>Reviewing editor</role><aff><institution>University of Queensland</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>c.r.pothast@lumc.nl</email> (CP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>11</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e82050</elocation-id><history><date date-type="received"><day>21</day><month>07</month><year>2022</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Pothast et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Pothast et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82050-v1.pdf"/><abstract><p>Detection of SARS-coronavirus-2 (SARS-CoV-2) specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells in SARS-CoV-2-unexposed donors has been explained by the presence of T cells primed by other coronaviruses. However, based on the relative high frequency and prevalence of cross-reactive T cells, we hypothesized CMV may induce these cross-reactive T cells. Stimulation of pre-pandemic cryo-preserved PBMCs with SARS-CoV-2 peptides revealed that frequencies of SARS-CoV-2-specific T cells were higher in CMV-seropositive donors. Characterization of these T cells demonstrated that membrane-specific CD4<sup>+</sup> and spike-specific CD8<sup>+</sup> T cells originate from cross-reactive CMV-specific T cells. Spike-specific CD8<sup>+</sup> T cells recognize SARS-CoV-2 spike peptide FVSNGTHWF (FVS) and dissimilar CMV pp65 peptide IPSINVHHY (IPS) presented by HLA-B*35:01. These dual IPS/FVS-reactive CD8<sup>+</sup> T cells were found in multiple donors as well as severe COVID-19 patients and shared a common T cell receptor (TCR), illustrating that IPS/FVS-cross-reactivity is caused by a public TCR. In conclusion, CMV-specific T cells cross-react with SARS-CoV-2, despite low sequence homology between the two viruses, and may contribute to the pre-existing immunity against SARS-CoV-2.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100016036</institution-id><institution>Health~Holland</institution></institution-wrap></funding-source><award-id>LSHM19088</award-id><principal-award-recipient><name><surname>Heemskerk</surname><given-names>Mirjam HM</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>1159272</award-id><principal-award-recipient><name><surname>Gras</surname><given-names>Stephanie</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Bio-banked PBMCs were cryopreserved after informed consent from the respective donors, in accordance with the declaration of Helsinki. The samples from COVID-19 patients were part of a trial (NL8589) registered in the Dutch Trial Registry and approved by Medical Ethical Committee Leiden-Den Haag-Delft (NL73740.058.20).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Figure 1 - Source data 1 contains percentages underlying figure 1C-F. Figure 4 - Source data 1 contains the sequence data used to generate figures and the data have been deposited in SRA (NCBI) database under BioProjectID PRJNA891934.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Pothast CR</collab><collab>Hagedoorn RS</collab><collab>Heemskerk MHM</collab></person-group><year iso-8601-date="2022">2022</year><source>TCRa and TCRb sequences of HLA-B*35:01/IPS-isolated T cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA891934">https://www.ncbi.nlm.nih.gov/bioproject/PRJNA891934</ext-link><comment>NCBI BioProject, PRJNA891934</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-82050-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>